Liangliang Ma
机构：Sichuan University, Meizhou City People's Hospital, West China Hospital of Sichuan University
发表论文 8 篇 · 总被引 40 次 · h-index 2
代表论文
- CRISPR/Cas9-based gene-editing technology for sickle cell disease (2023 · Gene · 被引 36)
- A Novel Conditioning Regimen Combining Selinexor with Melphalan Could Improve Survival of Patients with Multiple Myeloma (2024 · Blood · 被引 1)
- GethReplayer: a smart contract testing method based on transaction replay (2024 · International Journal of Web Information Systems · 被引 1)
- A novel conditioning regimen combining selinexor with melphalan Improves Survival in Patients with multiple myeloma:a prospective study (2025 · Blood)
- Research on Vehicle Detection Method Based on Improved YOLOv5s (2024)
- Zanubrutinib Plus R-CHOP (ZR-CHOP) in Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Who Were Positron Emission Tomography-Positive after Two Cycles of R-CHOP: A Single-Arm, Open-Label, Multicenter Prospective Study (2024 · Blood)